Literature DB >> 2907771

Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model.

B Nowicki1, J Vuopio-Varkila, P Viljanen, T K Korhonen, P H Mäkelä.   

Abstract

Mouse peritonitis induced by intraperitoneal injection of a virulent (LD50 4 x 10(5) E. coli 018:K1:H7 strain isolated from neonatal meningitis was studied. These bacteria are capable of producing both type 1 and S fimbriae, binding to mannose or sialic acid containing glycoconjugates, respectively; the production of both fimbrial types is subject to phase variation. A broth culture of the bacteria was fractionated into subpopulations containing either type 1 or S fimbriae or neither (nonfimbriated cells), and each fraction, grown in broth to logarithmic growth phase, was used to infect groups of mice. The type 1 fraction was associated with decreased virulence as the fraction was eliminated rapidly without causing a progressive infection even at 10(6) bacteria/mouse, whereas both S and nonfimbriated cells started rapid multiplication in the peritoneal cavity and spread to the blood. In nonfibriated cells, however, S fimbriae production was induced at the same time so that at 1 h after injection, 60-70% of the bacteria in the peritoneal cavity and in the blood of the mice had S fimbriae. The injected S-fimbriated fraction remained completely S-fimbriated. Rapid induction of S fimbriae also took place in vitro when the nonfimbriated bacteria were grown in mouse serum or peritoneal fluid. Anti-S serum protected the mice from a lethal dose of S-fimbriated bacteria.

Entities:  

Mesh:

Year:  1986        PMID: 2907771     DOI: 10.1016/0882-4010(86)90066-5

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  23 in total

1.  The cellular form of human fibronectin as an adhesion target for the S fimbriae of meningitis-associated Escherichia coli.

Authors:  A Sarén; R Virkola; J Hacker; T K Korhonen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli.

Authors:  B Nowicki; C Svanborg-Edén; R Hull; S Hull
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

3.  Virulence patterns and long-range genetic mapping of extraintestinal Escherichia coli K1, K5, and K100 isolates: use of pulsed-field gel electrophoresis.

Authors:  M Ott; L Bender; G Blum; M Schmittroth; M Achtman; H Tschäpe; J Hacker
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

4.  HbiF regulates type 1 fimbriation independently of FimB and FimE.

Authors:  Yi Xie; Yufeng Yao; Vitaliy Kolisnychenko; Ching-Hao Teng; Kwang Sik Kim
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Binding characteristics of Escherichia coli adhesins in human urinary bladder.

Authors:  R Virkola; B Westerlund; H Holthöfer; J Parkkinen; M Kekomäki; T K Korhonen
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

Review 6.  Common themes in microbial pathogenicity.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Rev       Date:  1989-06

7.  S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536.

Authors:  U Dobrindt; G Blum-Oehler; T Hartsch; G Gottschalk; E Z Ron; R Fünfstück; J Hacker
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Cloning and characterization of a new type of fimbria (S/F1C-related fimbria) expressed by an Escherichia coli O75:K1:H7 blood culture isolate.

Authors:  M Pawelzik; J Heesemann; J Hacker; W Opferkuch
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  Sialyloligosaccharide chains of laminin as an extracellular matrix target for S fimbriae of Escherichia coli.

Authors:  R Virkola; J Parkkinen; J Hacker; T K Korhonen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae.

Authors:  A K May; C A Bloch; R G Sawyer; M D Spengler; T L Pruett
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.